Found: 3
Select item for more details and to access through your institution.
A Randomized, Double‐Blind, Placebo‐Controlled, Multiple Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of ELX‐02 in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 8, p. 859, doi. 10.1002/cpdd.914
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of ELX‐02, a Potential Treatment for Genetic Disorders Caused by Nonsense Mutations, in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 8, p. 984, doi. 10.1002/cpdd.647
- By:
- Publication type:
- Article
Phase 1 Renal Impairment Trial Results Supports Targeted Individualized Dosing of ELX‐02 in Patients With Nephropathic Cystinosis.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 7, p. 923, doi. 10.1002/jcph.1807
- By:
- Publication type:
- Article